PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
L&G Healthcare Breakthrough UCITS ETF USD Acc (XML...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINIE00BK5BC677
WKNA2PM51
IssuerLegal & General
Inception DateJun 26, 2019
CategoryHealth & Biotech Equities
Leveraged1x
Index TrackedROBO Global Healthcare Technology and Innovation
DomicileIreland
Distribution PolicyAccumulating
Asset ClassEquity

Expense Ratio

XMLH.DE features an expense ratio of 0.49%, falling within the medium range.


Expense ratio chart for XMLH.DE: current value at 0.49% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.49%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in L&G Healthcare Breakthrough UCITS ETF USD Acc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%JuneJulyAugustSeptemberOctoberNovember
10.72%
14.31%
XMLH.DE (L&G Healthcare Breakthrough UCITS ETF USD Acc)
Benchmark (^GSPC)

Returns By Period

L&G Healthcare Breakthrough UCITS ETF USD Acc had a return of 7.81% year-to-date (YTD) and 27.61% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date7.81%25.23%
1 month5.56%3.86%
6 months10.73%14.56%
1 year27.61%36.29%
5 years (annualized)N/A14.10%
10 years (annualized)N/A11.37%

Monthly Returns

The table below presents the monthly returns of XMLH.DE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-1.06%1.96%1.78%-6.37%1.77%1.39%5.49%-1.62%0.84%-2.49%7.81%
20235.64%-1.11%-2.57%-0.21%-2.15%3.19%0.60%-5.04%-8.82%-12.02%8.84%11.65%-4.50%
2022-13.41%0.18%0.53%-9.80%-5.71%-2.13%11.53%-4.21%-3.41%1.31%-2.96%-3.76%-29.13%
20219.66%-2.82%-1.59%3.72%-5.24%10.78%-1.53%2.90%-3.56%1.27%-5.34%0.64%7.65%
202010.68%2.22%2.62%4.82%1.50%3.93%1.28%8.81%8.17%53.04%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of XMLH.DE is 44, suggesting that the investment has average results relative to other ETFs in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of XMLH.DE is 4444
Combined Rank
The Sharpe Ratio Rank of XMLH.DE is 4848Sharpe Ratio Rank
The Sortino Ratio Rank of XMLH.DE is 5151Sortino Ratio Rank
The Omega Ratio Rank of XMLH.DE is 4646Omega Ratio Rank
The Calmar Ratio Rank of XMLH.DE is 2323Calmar Ratio Rank
The Martin Ratio Rank of XMLH.DE is 5353Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for L&G Healthcare Breakthrough UCITS ETF USD Acc (XMLH.DE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


XMLH.DE
Sharpe ratio
The chart of Sharpe ratio for XMLH.DE, currently valued at 1.69, compared to the broader market-2.000.002.004.006.001.69
Sortino ratio
The chart of Sortino ratio for XMLH.DE, currently valued at 2.54, compared to the broader market-2.000.002.004.006.008.0010.0012.002.54
Omega ratio
The chart of Omega ratio for XMLH.DE, currently valued at 1.30, compared to the broader market1.001.502.002.503.001.30
Calmar ratio
The chart of Calmar ratio for XMLH.DE, currently valued at 0.59, compared to the broader market0.005.0010.0015.000.59
Martin ratio
The chart of Martin ratio for XMLH.DE, currently valued at 9.47, compared to the broader market0.0020.0040.0060.0080.00100.00120.009.47
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.94, compared to the broader market-2.000.002.004.006.002.94
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.93, compared to the broader market-2.000.002.004.006.008.0010.0012.003.93
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.55, compared to the broader market1.001.502.002.503.001.55
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 3.89, compared to the broader market0.005.0010.0015.003.89
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 19.19, compared to the broader market0.0020.0040.0060.0080.00100.00120.0019.19

Sharpe Ratio

The current L&G Healthcare Breakthrough UCITS ETF USD Acc Sharpe ratio is 1.69. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of L&G Healthcare Breakthrough UCITS ETF USD Acc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
1.69
2.74
XMLH.DE (L&G Healthcare Breakthrough UCITS ETF USD Acc)
Benchmark (^GSPC)

Dividends

Dividend History


L&G Healthcare Breakthrough UCITS ETF USD Acc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-35.10%
0
XMLH.DE (L&G Healthcare Breakthrough UCITS ETF USD Acc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the L&G Healthcare Breakthrough UCITS ETF USD Acc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the L&G Healthcare Breakthrough UCITS ETF USD Acc was 51.48%, occurring on Oct 30, 2023. The portfolio has not yet recovered.

The current L&G Healthcare Breakthrough UCITS ETF USD Acc drawdown is 35.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-51.48%Feb 16, 2021694Oct 30, 2023
-6.7%Aug 10, 202019Sep 4, 202015Sep 28, 202034
-6.69%May 26, 202012Jun 12, 20205Jun 23, 202017
-6.19%Oct 15, 202013Nov 2, 20205Nov 9, 202018
-5.82%Apr 8, 20201Apr 8, 20201Apr 14, 20202

Volatility

Volatility Chart

The current L&G Healthcare Breakthrough UCITS ETF USD Acc volatility is 4.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%JuneJulyAugustSeptemberOctoberNovember
4.66%
5.44%
XMLH.DE (L&G Healthcare Breakthrough UCITS ETF USD Acc)
Benchmark (^GSPC)